CIBC Private Wealth Group’s Avadel Pharmaceuticals AVDL Stock Holding History

CIBC Private Wealth Group’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$172K	Hold	8,000	–	–	﹤0.01%	1261
2025 Q3	$122K	Buy	+8,000	New	+$104K	﹤0.01%	1406
2025 Q2	–	Sell	-78,253	Closed	-$516K	–	3095
2025 Q1	$516K	Hold	78,253	–	–	﹤0.01%	798
2024 Q4	$837K	Hold	78,253	–	–	﹤0.01%	737
2024 Q3	$1.03M	Buy	+78,253	New	+$1.19M	﹤0.01%	684
2024 Q2	–	Sell	-58,934	Closed	-$982K	–	3156
2024 Q1	$982K	Sell	58,934 -4,695	-7%	-$69.9K	﹤0.01%	679
2023 Q4	$898K	Sell	63,629 -29,799	-32%	-$350K	﹤0.01%	657
2023 Q3	$962K	Sell	93,428 -82	-0.1%	-$1.1K	﹤0.01%	614
2023 Q2	$1.54M	Sell	93,510 -49,575	-35%	-$644K	﹤0.01%	530
2023 Q1	$1.31M	Buy	143,085 +4,080	+3%	+$33.5K	﹤0.01%	570
2022 Q4	$995K	Sell	139,005 -20,000	-13%	-$140K	﹤0.01%	531
2022 Q3	$797K	Sell	159,005 -6,000	-4%	-$33K	﹤0.01%	635
2022 Q2	$403K	Buy	165,005 +58,934	+56%	+$242K	﹤0.01%	744
2022 Q1	$724K	Sell	106,071 -59,284	-36%	-$408K	﹤0.01%	686
2021 Q4	$1.34M	Hold	165,355	–	–	﹤0.01%	592
2021 Q3	$1.62M	Hold	165,355	–	–	﹤0.01%	537
2021 Q2	$1.11M	Hold	165,355	–	–	﹤0.01%	639
2021 Q1	$1.5M	Buy	165,355 +100,350	+154%	+$811K	﹤0.01%	593
2020 Q4	$434K	Hold	65,005	–	–	﹤0.01%	797
2020 Q3	$328K	Buy	+65,005	New	+$473K	﹤0.01%	765
2020 Q1	–	Sell	-150,000	Closed	-$1.13M	–	842
2019 Q4	$1.13M	Hold	150,000	–	–	﹤0.01%	556
2019 Q3	$624K	Hold	150,000	–	–	﹤0.01%	654
2019 Q2	$434K	Buy	+150,000	New	+$258K	﹤0.01%	737

Other funds holding AVDL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GJL

Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC Private Wealth Group's AVDL Position: Q4 2025 in Review

CIBC Private Wealth Group held its Avadel Pharmaceuticals (AVDL) position steady in Q4 2025 at 8,000 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #1261.

CIBC Private Wealth Group first reported a position in AVDL in Q2 2019 and has held it in 23 quarters since. The position peaked at $1.62M in Q3 2021. 207 funds tracked by Wall St. Rank hold AVDL as of Q4 2025.

CIBC Private Wealth Group held 8,000 shares of Avadel Pharmaceuticals worth $172K as of Q4 2025.
CIBC Private Wealth Group left its Avadel Pharmaceuticals share count unchanged in Q4 2025.
Avadel Pharmaceuticals made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1261 holding.
CIBC Private Wealth Group first reported a position in Avadel Pharmaceuticals in Q2 2019 and has held it in 23 quarters since.
CIBC Private Wealth Group's Avadel Pharmaceuticals position peaked at $1.62M in Q3 2021.
207 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.